Cargando…

Long‐term humoral immunity decline in hemodialysis patients following severe acute respiratory syndrome coronavirus 2 vaccination: A cohort study

BACKGROUND AND AIMS: Dialysis patients are extremely vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection with high rates of hospitalization and mortality rates. In January 2021, the University of Virginia Dialysis Program initiated a program‐wide vaccination campaign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goggins, Eibhlin, Sharma, Binu, Ma, Jennie Z., Gautam, Jitendra, Bowman, Brendan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528757/ https://www.ncbi.nlm.nih.gov/pubmed/36210878 http://dx.doi.org/10.1002/hsr2.854

Ejemplares similares

SARS‐CoV‐2 booster effect and waning immunity in hemodialysis patients: A cohort study
por: Goggins, Eibhlin, et al.
Publicado: (2023)

Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis
por: Atahan, Ersan, et al.
Publicado: (2023)

Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Gautam, Nandan, et al.
Publicado: (2021)

Clinical perspectives on vagus nerve stimulation: present and future
por: Goggins, Eibhlin, et al.
Publicado: (2022)

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2022)

Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients
por: John, Binu V., et al.
Publicado: (2022)

Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation
por: Pillai, Shiv
Publicado: (2022)

Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
por: Mungmunpuntipantip, Rujititka, et al.
Publicado: (2023)

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
por: Duarte, Luisa F, et al.
Publicado: (2023)

Longitudinal analysis of risk factors associated with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hemodialysis patients and healthcare personnel in outpatient hemodialysis centers
por: Gandra, Sumanth, et al.
Publicado: (2022)

Humoral response to viral vector COVID-19 vaccine in hemodialysis patients
por: Raja, Niranjan, et al.
Publicado: (2022)

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
por: Mwimanzi, Francis, et al.
Publicado: (2023)

Impaired humoral immune response to hepatitis B vaccine in patients on maintenance hemodialysis
por: Mahallawi, Waleed H., et al.
Publicado: (2023)

Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

Decline of immune humoral response after BNT162b2 vaccine
por: Ferri, Sonia, et al.
Publicado: (2022)

Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports
por: Emeribe, Anthony Uchenna, et al.
Publicado: (2021)

Severe acute respiratory syndrome in a hemodialysis patient
por: Kwan, Bonnie Ching-Ha, et al.
Publicado: (2003)

Antibody response in patients undergoing chronic hemodialysis post-severe acute respiratory syndrome coronavirus 2 vaccination: A prospective observational study
por: Choi, Heejung, et al.
Publicado: (2023)

Humoral Response to Hepatitis B and COVID-19 Vaccine among Maintenance Hemodialysis Patients
por: Nacasch, Naomi, et al.
Publicado: (2022)

Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
por: Miyazaki, Ryoichi, et al.
Publicado: (2023)

Humoral Response to SARS-CoV-2 in Hemodialysis Patients
por: Steers, Nicholas J.
Publicado: (2021)

Adequacy of Hemodialysis Serves as an Independent Predictor of Humoral Response to ChAdOx1 Prime-Boost Vaccination in Hemodialysis Patients
por: Chen, Chun-Yu, et al.
Publicado: (2022)

Historical surveys reveal a long‐term decline in muskrat populations
por: Sadowski, Carrie, et al.
Publicado: (2021)

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines
por: Mahallawi, Waleed H, et al.
Publicado: (2023)

Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine
por: Yang, Jinyoung, et al.
Publicado: (2023)

Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France
por: Casenaz, Alice, et al.
Publicado: (2022)

Two episodes of severe acute respiratory syndrome coronavirus 2 infection in a patient on chronic hemodialysis: a note of caution
por: Torreggiani, M., et al.
Publicado: (2021)

Severe acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: An extraordinary pandemic
por: Singh, Sheetu, et al.
Publicado: (2020)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022)

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
por: Zhao, Wen-Man, et al.
Publicado: (2022)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing maintenance hemodialysis
por: Delgado Ureña, Ana, et al.
Publicado: (2023)

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
por: Joo, Yoosun, et al.
Publicado: (2023)

The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status
por: Jacobson-Naftali, Merav, et al.
Publicado: (2023)

Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
por: Kaplonek, Paulina, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome and Coronavirus
por: Hui, David S.C., et al.
Publicado: (2010)

Heterologous adenovirus‐vector/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipients
por: Mendizabal, Manuel, et al.
Publicado: (2022)

Clinical outcomes of hemodialysis patients infected with severe acute respiratory syndrome coronavirus 2 and impact of proactive chest computed tomography scans
por: Wang, Rui, et al.
Publicado: (2020)

Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts()()
por: Goggins, Eibhlin, et al.
Publicado: (2017)

Reprogramming of VEGF-mediated extracellular matrix changes through autocrine signaling
por: Goggins, Eibhlin, et al.
Publicado: (2023)

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy
por: Bukhari, Syed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n8860va0mlhhpu9e429rh4u4jf